Symbol
KLRS on Nasdaq
Investment type
Equity / Common Stock, $0.0001 par value per share
Latest Disclosed Ownership
283K shares
Security Ownership
1.5%

Invus Public Equities, L.P. ownership in Kalaris Therapeutics, Inc. Common Stock, $0.0001 par value per share (KLRS)

2025-07-29 - Invus Public Equities, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 283K shares of Kalaris Therapeutics, Inc. Common Stock, $0.0001 par value per share (KLRS). This represents 1.5% percent ownership of the company.